Evidence-Based Consensus on the Diagnosis and Treatment of Advanced HER2-Positive and HER2-Low Breast Cancer in Colombia
Mauricio Lema, Luz F. Sua, Abrahám José Hernández Blanquisett, William Mantilla, Marc Edy Pierre, Hernán Carranza, Julio Ricardo Zuluaga Peña, Aura Victoria Gutiérrez Raba, Sandra Ximena Franco

TL;DR
This paper provides updated clinical guidelines for treating advanced HER2-positive and HER2-low breast cancer in Colombia, aiming to standardize care and improve patient outcomes.
Contribution
The study offers the first evidence-based, nationally tailored clinical recommendations for HER2-related breast cancer in Colombia.
Findings
Twenty-two clinical recommendations were developed, covering diagnosis, treatment, and management of brain metastases.
Five recommendations were strong, while 17 were conditional due to local resource constraints.
The guidelines aim to standardize care and promote equitable access to therapies in Colombia.
Abstract
Background/Objectives: The management of advanced HER2-positive and HER2-low breast cancer is evolving rapidly. This study aimed to generate national, evidence-based clinical recommendations for Colombia, addressing the lack of standardized local guidance. Methods: A systematic literature search (2020–2024) was conducted. The evidence was evaluated using AGREE II, RoB 2, ROBINS-I, and JBI tools. Recommendations were developed using the GRADE approach and a structured modified Delphi consensus process involving 34 national experts. Results: A total of 22 clinical recommendations were formulated. These address HER2 quantification and reporting, first-line and subsequent-line therapy, and management of brain metastases. Five recommendations (23%) were classified as strong, supported by high-certainty evidence, while 17 (77%) were conditional, reflecting the need for adaptation to local…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Breast Cancer Therapies · HER2/EGFR in Cancer Research · Breast Cancer Treatment Studies
